scholarly journals Drug Therapy in Ulcerative Colitis

Author(s):  
Xue-Gang Guo ◽  
Xiang-Ping Wang ◽  
Chang-Tai Xu
2021 ◽  
Vol 11 (1) ◽  
pp. 438
Author(s):  
Andreea Nedelcu ◽  
Ofelia Mosteanu ◽  
Teodora Pop ◽  
Teodora Mocan ◽  
Lucian Mocan

There have been continuous advances in nanoscience since the beginning of the 21st century, and the emerging field of computational nanomedicine, the development of nanomaterial-based sensors or the prominent biomedical engineering applications should be mentioned. Intestinal disorders causing prolonged inflammation of the digestive tract, largely known as inflammatory bowel disease (IBD), include Crohn’s disease (CD) and ulcerative colitis (UC), have seen a significant increase in incidence rates. Nanoparticle-based approaches to locally target therapy could help regulate immune responses and act as an anti-inflammatory in individual patients diagnosed with IBD. The results of the paper emphasize the major role that nanoparticle-mediated drug delivery has in IBD treatment, giving IBD patients in remission the chance for a more effective drug therapy with a decreased medication load.


1993 ◽  
Vol 16 (3) ◽  
pp. 215-218 ◽  
Author(s):  
Asher A. Kornbluth ◽  
Peter Salomon ◽  
Henry S. Sacks ◽  
Roger Mitty ◽  
Henry D. Janowitz

1976 ◽  
Vol 21 (6) ◽  
pp. 441-447 ◽  
Author(s):  
B. I. Korelitz ◽  
S. C. Sommers

1992 ◽  
Vol 34 (3) ◽  
pp. 189-198 ◽  
Author(s):  
B Crotty ◽  
DP Jewell

1996 ◽  
Vol 110 (5) ◽  
pp. 466-467
Author(s):  
Michael Wareing ◽  
David Mitchell

AbstractA case of left otalgia in a patient suffering from longstanding ulcerative colitis is reported. The patient was treated for an exacerbation of his disease with courses of mesalazine and sulphasalazine during which time he developed otalgia. The otalgia disappeared with cessation of the drugs. It is concluded that in the absence of any other head and neck cause that the otalgia was a complication of the drug therapy.


Sign in / Sign up

Export Citation Format

Share Document